Press Releases
New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics
Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for...
Press Releases
Plasticell leads gene therapy manufacturing consortium with Great Ormond...
Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering gene therapy groups at UCL’s Institute of...
Press Releases
CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement...
CASI Pharmaceuticals, Inc , a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in...
Press Releases
Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In...
Processa Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have a high unmet...
Press Releases
ChargePoint Technology Reinforces Asia Presence withGrowth in China and...
Powder containment and aseptic transfer valve specialist, ChargePoint Technology has achieved triple-digit growth in key Asian markets and will be exhibiting its sterile and highly...
Press Releases
Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment...
Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lomb’sLevofree Multidose in France. This marks the first...
Press Releases
Orion Contract Manufacturing enters supply agreement with Peptonic Medical
Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.